A. Racca

发表

A small-molecule myosin inhibitor as a targeted multi-stage antimalarial

Paul V. Ruijgrok, E. Winzeler, J. Spudich, 2022, bioRxiv.

Contractile properties of developing human fetal cardiac muscle

M. Bamshad, M. Regnier, A. Beck, 2016, The Journal of physiology.

Loss of crossbridge inhibition drives pathological cardiac hypertrophy in patients harboring the TPM1 E192K mutation

M. Rynkiewicz, Jeffrey R. Moore, W. Lehman, 2021, The Journal of general physiology.

Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human induced pluripotent stem cells.

R. Moritz, M. Regnier, Deok‐Ho Kim, 2019, Cardiovascular research.

2-Deoxy adenosine triphosphate improves contraction in human end-stage heart failure.

M. Regnier, A. Stempien-Otero, Yuanhua Cheng, 2015, Journal of molecular and cellular cardiology.

The embryonic myosin R672C mutation that underlies Freeman-Sheldon syndrome impairs cross-bridge detachment and cycling in adult skeletal muscle.

M. Bamshad, M. Regnier, M. McMillin, 2015, Human molecular genetics.

Isolation and Mechanical Measurements of Myofibrils from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

M. Regnier, Deok‐Ho Kim, D. Mack, 2016, Stem cell reports.

Prolonged Relaxation Kinetics in Distal Arthrogryposis Skeletal Muscle Myofibrils with a MYH3 R672C Mutation

M. Bamshad, M. Regnier, A. Beck, 2014 .

Cell and Myofibril Contractile Properties of hiPSC-Derived Cardiomyocytes from a Patient with a MYH7 Mutation Associated with Familial Cardiomyopathy

M. Regnier, Deok‐Ho Kim, C. Poggesi, 2015 .

Contractility and kinetics of human fetal and human adult skeletal muscle

M. Bamshad, M. Regnier, A. Beck, 2013, The Journal of physiology.